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Abstract
Understanding the physiology of human neural stem cells (hNSCs) in the context of cell therapy for neurodegenerative
disorders is of paramount importance, yet large-scale studies are hampered by the slow-expansion rate of these cells. To
overcome this issue, we previously established immortal, non-transformed, telencephalic-diencephalic hNSCs (IhNSCs) from
the fetal brain. Here, we investigated the fate of these IhNSC’s immediate progeny (i.e. neural progenitors; IhNSC-Ps) upon
unilateral implantation into the corpus callosum or the hippocampal fissure of adult rat brain, 3 days after global ischemic
injury. One month after grafting, approximately one fifth of the IhNSC-Ps had survived and migrated through the corpus
callosum, into the cortex or throughout the dentate gyrus of the hippocampus. By the fourth month, they had reached the
ipsilateral subventricular zone, CA1-3 hippocampal layers and the controlateral hemisphere. Notably, these results could be
accomplished using transient immunosuppression, i.e administering cyclosporine for 15 days following the ischemic event.
Furthermore, a concomitant reduction of reactive microglia (Iba1+ cells) and of glial, GFAP+ cells was also observed in the
ipsilateral hemisphere as compared to the controlateral one. IhNSC-Ps were not tumorigenic and, upon in vivo engraftment,
underwent differentiation into GFAP+ astrocytes, and b-tubulinIII+ or MAP2+ neurons, which displayed GABAergic and
GLUTAmatergic markers. Electron microscopy analysis pointed to the formation of mature synaptic contacts between host
and donor-derived neurons, showing the full maturation of the IhNSC-P-derived neurons and their likely functional
integration into the host tissue. Thus, IhNSC-Ps possess long-term survival and engraftment capacity upon transplantation
into the globally injured ischemic brain, into which they can integrate and mature into neurons, even under mild, transient
immunosuppressive conditions. Most notably, transplanted IhNSC-P can significantly dampen the inflammatory response in
the lesioned host brain. This work further supports hNSCs as a reliable and safe source of cells for transplantation therapy in
neurodegenerative disorders.
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Introduction
The isolation of multipotent neural stem cells (NSCs) from the
human central nervous system (CNS) has spurred the investigation
of new cell-therapy approaches for brain injuries and neurode-
generative diseases. NSCs, which reside in specialized regions of
the adult CNS, in particular in the subventricular zone (SVZ) [1–
3] and the dentate gyrus of the hippocampus (DG), possess life-
long self-renewal and the ability to generate neurons, astrocytes
and oligodendrocytes. Although NSCs play a central role in CNS
development and cellular homeostasis throughout adulthood
[2,4,5], limited spontaneous recovery is known to occur following
brain damage [6,7]. Nonetheless, the integration of functional new
neurons following injury can be achieved by the mobilization of
endogenous stem cells [8,9] or by transplanting new cells from
different sources, as shown in experimental models of ischemia
[10–12].
Also owing to the resilience of hNSCs (human neural stem cells)
to expansion ex vivo, a relatively limited number of studies has
investigated the use of hNSCs for the experimental treatment of
cerebral ischemia [13]. An initial solution to this issue has come
from the establishment of non-transformed, v-myc immortalized
hNSCs, to give rise to stable cell lines (IhNSCs) [14], that can be
rapidly expanded in vitro and retains the features of parental NSCs,
such as proliferation, self-renewal, functional stability and multi-
potency.
In this paper, we demonstrate that the IhNSC’s immediate
progeny, represented by neural progenitors undergoing early
differentiation phases (IhNSC-Ps) exhibit widespread integration
ability and long-term survival when transplanted into the brain of
adult rats lesioned by transient global ischemia. IhNSC-Ps
generated both glial cells and mature neurons, both in the cortex
and the corpus callosum. We also found that IhNSC-P-derived
neuronal cells were able to establish heterotypic synaptic junctions
with the host tissue after 4 months from transplantation.
Although several studies have reported a weak host’ immuno-
genic response against transplanted hNSCs and their progeny in
the brain, this issue has never been unraveled [15–18]. Thus, we
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progeny and were able to show that grafted IhNSC-Ps have the
ability to integrate in the post-ischemic, inflammatory environ-
ment that develops in the brain after injury, also dampening the
local inflammatory reaction at the integration sites. All of the
above was accomplished even using transient immunosuppression.
Materials and Methods
Transient Global Ischemia
All animal experimental protocols were approved by the Ethics
Review Committee for Animal Experimentation of the Italian
Ministry of Health (protocol number 37/2007-B). Adult male
Sprague-Dawley rats (350–400 gr) were anesthetized with keta-
mine (60 mg/Kg) and Xylazine (10 mg/Kg). The common
carotid arteries were exposed bilaterally by means of a ventral
midline incision and occluded with microvascular clips for 10
minutes. The body temperature of the rats was mantained at
37u60.5uC by a heating pad provided with a rectal probe. All
physiological parameters were monitored and recorded through-
out the surgery with BIOPAC Data Acquisition System. During
the 10 minutes of carotid occlusion, mean blood pressure was
maintained at 50 mmHg by withdrawal of blood from the femoral
artery previously exsposed and incannulated with PE50 tubing
connected to a BIOPAC system and to a collector. After the
removal of the clips from the carotid arteries, the blood was
reinjected into the femoral artery. After the surgery, the rats were
daily treated with subcutaneous injections of antibiotics (Enro-
floxacin 10–15 mg/Kg) and painkillers (Carprofen 5 mg/Kg) for
one week.
Cell Preparation
To generate IhNSC-Ps for transplantation, IhNSC neuro-
spheres, cultured as described in De Filippis et al. 2007, were
mechanically dissociated and transferred onto laminin (Roche,
Base, Switzerland, http://www.roche-applied-science.com)- coat-
ed tissue culture flasks (or glass coverslips for immunostaining
assays) at a density of 1610
4 cells per cm
2 in the presence of FGF2
(20 ng/ml) for 3 days. The day of transplant IhNSC-Ps were
collected with VERSENE (Gibco, Aukland, NZ) and transferred
into control medium ad the density of 1610
5 cells/mL.
Characterization was performed by immunostaining assays with
primary antibodies b-TubulinIII (b-Tub, TUJ-1, 1:400, Covance),
Galactocerebroside C (GalC, 1:100, Chemicon), Glial fibrillary
acidic protein (GFAP, 1:500, Chemicon), Green Fluorescent
Protein (GFP, 1:500, Sigma), Microtubule-associated protein 2
(MAP2, 1:200, Sigma), Doublecortin (DCX, 1:200, Santa Cruz)
and Neural Cell Adhesion Molecule (NCAM, 1:100, Santa Cruz).
Transduction of IhNSC with lenti-gfp
Transduction of IhNSC with a lentiviral vector carrying the gfp
gene was carried as described in [19,20] and the percentage of
GFP+ IhNSC reached 95%. After 4 passages they were used for
transplantation.
Cell Transplantation
Experimental design (Figure S3) included the following animal
groups: healthy control animals (n=4), healthy control animals
transplanted with IhNSC-Ps in the corpus callosum (n=2/each
time point), healthy control animals transplanted with IhNSC-Ps
in the hippocampal fissure (n=2/each time point) and lesioned
animals transplanted with IhNSC-Ps (n=2/each time point) and
GFP+ IhNSC-Ps cells (n=3/each time point) [19] in the corpus
callosum (n=5 tot/each time point) or in the hippocampal fissure
(n=5 tot/each time point). The four groups of transplanted
animals were transiently immunosuppressed with cyclosporine (see
below) and sacrificed at 7 days, 2 weeks, 1 month, 3 and 4 months
from transplantation and analyzed in parallel with healthy
controls.
In the paralel a set of lesioned animals was transplanted with
GFP+ IhNSC-Ps in the periventricular region next to cc (n=3
each time point) or in the hippocampal fissure (n=3 each time
point), constitutively immunosuppressed and sacrificed 1, 3 and 4
months later.
Rats were anesthetized with an intraperitoneal injection of
ketamine (60 mg/Kg) and Xylazine (10 mg/Kg), placed in a
sterotactic frame (David Kopf Instruments, Tujunga, CA) and
injected with 2 mL of cell suspension (1610
5 cells/mL control
medium) using a Hamilton syringe to the hippocampal fissure
(anteroposterior: 25.3; lateral: +3.0; dorsoventral: 23.0) or to the
posterior periventricular region in the cc (anteroposterior: 25.3;
lateral, +3; dorsoventral: 22). All animals were immunosoppressed
with Cyclosporine A (15 mg/Kg; Sandimmun, Novartis) admin-
istered subcutaneously starting 2 days before transplantation and
for the duration of the study or for 14 days for transient
immunosuppression experiments.
Tissue Processing and Immunohistochemistry
Rats were anestethized with an intraperitoneal injection of
Avertin (300 mg/Kg) and transcardially perfused-fixed with 4%
paraformaldehyde. Brains were fixed overnight in 4% parafor-
maldeyde at 4uC, then sequentially transferred in 10%, 20% and
30% sucrose solutions. Brains were then cryopreserved (Killik,
Bio-Optica, Italy), frozen and stored at 280uC. Coronal sections
(18 mm thick) were obtained using a cryostat, transferred onto
Super Frost/Plus object glasses (Menzel-Glaser, Braunschweig,
Germany) and stored at 220uC. Sections were let dry at room
temperature for 1 hour, rehydrated in phosfate-buffered saline
and blocked with phosphate-buffered saline containing 10%
Normal Goat Serum and 0,3% Triton X-100 for 90 minutes at
room temperature. The following primary antibodies and dilutions
were used: Human Specific Nuclei (HuN, 1:100, Chemicon), b-
TubulinIII (TUJ-1, 1:400, Covance), Gamma-aminobutyric acid
(GABA, 1:500, Sigma), Glial fibrillary acidic protein (GFAP,
1:500, Chemicon), Green Fluorescent Protein (GFP, 1:500,
Sigma), Glutamate (GLUTA, 1:500, Sigma), Microtubule-associ-
ated protein 2 (MAP2, 1:200, Sigma), Doublecortin (DCX, 1:200,
Santa Cruz), Neural Cell Adhesion Molecule (NCAM, 1:100,
Santa Cruz), human specific Ki67 (Ki67, 1:200, Novocastra), Iba1
(1:100, Wako). The fluorescent secondary antibodies used were
labelled with Cy3 (1:800, Jackson), Cy2 (1:200, Jackson), Alexa
Fluor 546 and 488 (1:800, Molecular Probes). DAPI (ROCHE)
was used as nuclear marker. Immunofluorescence-labeled sections
were viewed under a fluorescence microscope (Zeiss Axioplan 2
imaging) and a confocal microscope (Leica Dmire2).
Quantification of cell death in the CA1 layer, survival of
transplanted cells and micro/astroglial cells
The percentage of dying cells was assessed by counting the
pyknotic nuclei over total nuclei into the CA1 layer of lesioned and
healthy control animals in serial brain sections (each 200 mm) as
described below (n=3 rats/time point).
At different time points, the rate of survival of IhNSC-Ps was
evaluated by counting GFP+ or HuN+ cells in serial brain sections
(each 200 mm apart) spanning the graft area of n=3 rats per time
point. The total number of surviving transplanted cells was
calculated for the whole graft using Abercrombie formula [21].
Data is presented as the percentage of surviving cells over total
hNSCs into Ischemic Brain
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among the animals of each experimental group.
The percentage of Iba1+ or GFAP+ cells was counted by
sampling three field in the hippocampal region of healthy or
lesioned rats at 3, 7, 14 and 30DAI.
For all the quantifications an average number of 3 sections was
counted per rat spanning about 500 mm along the antero-posterior
axis.
Statistical analysis was performed by one-way ANOVA. Data is
reported as means6SEM. (*P,0.05. **P,0.01, ***P,0.001).
GFP immunolabeling and electron microscopy
Animals were perfused with 4% paraformaldehyde in phos-
phate buffer (0.12 M, pH 7.4). Brain samples were then cut using
a vibratome (section thickness 30–40 mm). Free-floating brain
slices were washed in Tris-buffered saline (TBS) and pre-incubated
in 3% goat normal serum (NGS) in TBS for 30 min. Cells were
also fixed with 4% formaldehyde and rinsed in TBS. Sections and
cells were subsequently incubated with a rabbit anti-GFP antibody
(1:250 for brain slices, 1:650 for cell cultures; Chemicon
International) overnight at 4uC in 1% NGS/TBS. A secondary
antibody (goat anti-rabbit HRP-labeled, 1:250 dilution; PerkinEl-
mer, Boston, MA) was used for 1 h at room temperature before
developing the immunoreactive signal determined by the reaction
of 3,39-diaminobenzidine tetrahydrochloride (DAB; Sigma, St.
Louis, MO) with H2O2.
Immunolabeled samples were post-fixed in 1% OsO4 in
cacodylate buffer (0.12 M, pH 7.4) for 45–60 min, dehydrated
and embedded in Epoxy resin. Ultramicrotome (Ultracut E,
Reichert-Jung) 60 nm sections (both rat hippocampus and
cultured cells) were then examined by a Philips CM 10
transmission electron microscope. Images were taken with a Mega
View II digital camera (Soft Imaging System).
Results
We have previously shown that IhNSC transplantated into the
immunodficient SCID mice brain can survive for as long as 6
months [14]. Nonetheless, pre-clinical and, most important,
clinical neural transplantation are based on the concept that
continuous immunosuppressive treatments are to be used to avoid
donor cell rejection [18]. In addition, the possibility that the stroke
heavy inflammatory environment (see Fig. 1) might enhance cell
rejection compounds the problem further. In this view, we
performed experiments in which animals transplanted with
GFP-expressing IhNSC-Ps were treated with cyclosporine, either
continuously (starting on the first day after ischemia (DAI 1) till the
end of the experiment) or only transiently, i.e. for only two weeks,
starting on DAI 1 and finishing on DAI 14. Tissues were analyzed
1, 3 and 4 months after implantation. Much to our surprise, no
significant differences in the survival or integration were detected
in transiently immunosuppressed animals (56.7%; n=17/30) as
compared to those receiving cyclosporine for the whole duration of
the experiments (66.7%; n=10/15). In considering that the two
types of immunosuppressive protocols yielded overlapping results,
the data presented below refer to milder one, i.e the transient
administration of cyclosporine administered in the peri-transplan-
tation period (two days before cell injection, all the way to 12 days
after the latter took place).
Evaluation of the ischemic lesion
The lesion generated by transient global ischemia in the central
nervous system is widespread and involves most brain districts.
Notwithstanding, cortical areas and the CA1 layer of the
hippocampus (Figure S1A–C) are known to be the most affected
by this type of injury [22,23]. In this view, in order to assess the
ability of I-hNSC-P to integrate following ischemic brain tissue
damage, we focused our study on the hippocampal region and
standardized our investigation by quantifying the fraction of
pyknotic nuclei in the CA1 layer, as detected by hematoxilin-eosin
staining (Fig. 1A and B and Figure S1C). Therein, the fraction of
dead cells amounted to approximately 75% of the total CA1 cells
at 3 and 14 DAI, with their number progressively decreasing to
60% at 90 DAI, as compared to the physiological 25% fraction in
control animals (Fig. 1C and Figure S1F). Given the inflammatory
nature of this kind of ischemic injury, we also investigated the
activation of microglia and astroglia during the subacute phase of
the lesion, that is at 3 days (Figure S1D–F) and 1 week from
ischemia: no significative changes in the inflammatory environ-
ment were detected between these two time points. In the lesioned
brain, Iba1+ cells presenting an ameboid morphology, typical of
reactive, macrophagic microglia (Fig. 1D and E) – in sharp
contrast with the star-shaped resting microglia found in the non-
lesioned brain (Fig. 1F) – were dramatically increased both in the
CA1 layer and in the hilus of the dentate gyrus (Fig. 1G) as
compared to control animals (Fig. 1H). This was consistent with
the data concerning the analysis of reactive gliosis by GFAP
immunostaining, showing a striking alteration of astrocyte
morphology (Fig. 1I) characterized by thicker and shorter
processes in the lesioned brain as compared the healthy controls
(Fig. 1L).
IhNSC-Ps efficiently survive after transplantation into the
ischemic rat brain
In order to contribute to the neural regeneration in the early
phases following tissue damage, IhNSC-Ps cells were transplanted
nearby the CA1 layer soon after lesioning. Previous results with
various transplantation paradigms in several animal models have
shown that transplantation of undifferentiated NSCs cells from
neurospheres generate mainly glial progenitors upon engraftment
[20,24] or remain undifferentiated in vivo [25,26]. Hence, we
decided to commit the IhNSCs’ progeny in vitro, prior to
implantation. To do this, we pre-differentiated IhNSCs for 3 days
in the presence of FGF2 in order to induce early neuronal
progenitors’ proliferation and to favour their fate choice towards
the neuronal lineage [27,28]. By this, the IhNSC-Ps used for
transplantation contained cells of the neuronal lineage, that
expressed both the early markers Dcx and NCAM (21.9764.21%
and 21.1164.5%, of the total differentiated cells, respectively;
Figure S2A, B and F), and the late markers b-Tub (13.3762.71%,
Figure S2C and F) and MAP2 (6.1264.1%, Figure S2D and F), as
well as astroglial GFAP+ (15.9163.91% Figure S2C and F) and
oligodendroglial GalC+ (8.662.65%, Figure S2E and F) cells. This
was quite different from IhNSC cultured in the presence of EGF
and FGF2 (neurospheres) which, in turn, contained only sporadic
b-Tub+ cells and low percentages of MAP2+ (3.5761.75%) and
GalC+ (5.2560.77%) cells. As expected for a population intended
to contain early transient dividing progenitors, most IhNSC-Ps
were actively proliferating, with 71.166.6% (Figure S2F) being
positive for Ki67 (Figure S2A, B and D), as compared to
46.463.5% in undifferentiated IhNSC.
The IhNSC-Ps were injected into the posterior periventricular
region, next to the corpus callosum or in the hippocampal fissure
of rats at 3 DAI (Figure S3). Integrated surviving cells were
detected in approximately 60.6% (n=37/61) of the transplanted,
injured animals, as compared to 25% (n=7/28) in the control
animals (not lesioned) receiving the same cells. This is in
agreement with previous findings showing that the presence of
hNSCs into Ischemic Brain
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the adult brain tissue [29]. In the injured animals where
engraftment was successful, the average survival rate of IhNSC-
Ps was 19.561,4% of the total transplanted cells and remained
unchanged for over 4 months. Fourteen days after transplantation
into the posterior periventricular region, donor cells were found to
be located close to the injection site (n=4), (Fig. 2A). By 30 DAI,
IhNSC-Ps migrated medially and laterally, along the myelin fibers
of the corpus callosum and clusters of donor cells displayed long
neuronal-like processes, which were directed towards the corpus
callosum, with some of the cells migrating to the upper cortical
layer (n=3) (Fig. 2B and C9,C 0).
At 14 DAI, IhNSC-Ps injected into the hippocampus were
found to integrate into the DG (n=3) (Fig. 2D) and in the
subgranular zone (SGZ) (n=3) (Fig. 2E and F), crossing the hilus
and reaching the lower SGZ by 30 DAI. A subset of IhNSC-Ps
presented a stem cell-like morphology [30,31], with the cell body
nested in the SGZ and tangential processes extending along the
border of the granule cell layer and hilus (Fig. 2F, arrow). No
IhNSC-P cells were detected in the contralateral hemisphere at 2
and 4 weeks after transplantation. In control (unlesioned) animals,
IhNSC-Ps were confined to the injection site (data not shown).
The colocalization of GFP with the human specific antigen HuN
(Fig. 2F inset) confirmed the identity of these cells as donor cells.
This analysis demonstrates that IhNSCs efficiently survive in
vivo and that their engraftment and migration capacities are
improved in a lesioned brain, which is consistent with previous
results showing that injury generates a local environment
permissive for the integration of xenotransplanted cells [17,29,32].
IhNSC-Ps give rise to neuronal cells in vivo
Next, we evaluated the differentiation of IhNSC-Ps into specific
neuronal and glial phenotypes following transplantation into the
ischemic environment by analyzing the colocalization of selective
markers for neurons, astroglial and oligodendroglial cells with the
anti-human specific antibody anti-huN. This was carried out on
IhNSC-Ps that were not tagged with GFP, in order to rule out
possible effects on their differentiation properties, as consequence
of viral transduction with the GFP expression construct.
At one and three months post transplantation, IhNSC-Ps
migrating through the corpus callosum and localizing into the DG
were found to be relatively immature neuronal cells, expressing
NCAM protein (corpus callosum, Fig. 3A) or Dcx (dentate gyrus,
Fig. 3B). A subset of HuN+ cells had further matured into
neuronal cells expressing b-Tub+ (11.36 0.8% over total HuN+
cells) (Fig. 3C) and MAP2+ (marker of dendritic neuronal
processes), found in sporadic cell clusters or as isolated elements
(Fig. 3D) within the corpus callosum and cortex. Such clusters
seemed to have arisen through the in vivo, transient proliferation
of single donor cells, as supported by the sporadic expression of
Ki67 observed in HuN+ cells (Fig. 3E and inset). This would be in
agreement with recent data reporting that ischemic injury
Figure 2. GFP-IhNSC-Ps survive in the ischemic brain. (A–C0) IhNSC-Ps into the cc at 14 (A) and 30 (B) days post transplant. Long processes
from donor cells directed toward the cc (C9) and the upper cortical layer (C0). (D–F) Distribution of IhNSC-Ps along the SGZ at 14 days (D) and
migrating to the lower SGZ at 30 days (E). Single GFP-IhNSC-Ps with tipical stem cell phenotype in the SGZ (F, arrow). Confocal analysis of
colocalization of HuN with GFP (inset in F). cc: corpus callosum, GZ: granular zone, SGZ: subgranular zone, DG: dentate gyrus. Scale bars: A, F, F inset:
10 mm, C9 and C0:2 0mm, B, D, E: 50 mm.
doi:10.1371/journal.pone.0014035.g002
Figure 1. Neuronal loss and inflammation in the ischemic hippocampus. (A–B) Damaged cells at 14DAI (pyknotic nuclei, arrows) versus
normal CA1 cells (B arrowhead). (C) Quantification of damaged cells in control and lesioned animals. (D–F) Iba1+ microglial cells with ameboid
(lesioned hippocampus D–E) or stellate (control F) morphology. (G–H) Increase of microglia (Iba1+ cells) in the lesioned hippocampus (G, 7DAI) with
respect to control (H). (I–L) Morphology of astroglial cells in the lesioned hippocampus (I, 7DAI) and control (L). Scale bars: A, B: 5 mm, D, E and F:
10 mm, G, H, I and L: 50 mm.
doi:10.1371/journal.pone.0014035.g001
hNSCs into Ischemic Brain
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of local precursors [33]. We also observed IhNSC-P-derived,
stellate GFAP+/HuN+ astrocytes (29.763.03% over total HuN+
cells) amongst the engrafted, surviving cells (Fig. 3F), but failed in
detecting oligodendroglial cells.
Altogether, the results above show that IhNSC-Ps can differentiate
towards the neuronal and astroglial lineages in the ischemic brain.
Both immature migratory neuroblasts and more mature b-Tub+ and
MAP2+ neuronal cells are produced throughout this process.
Neuronal subtypes derived from grafted IhNSC-Ps
We have previously shown that IhNSCs [14] can differentiate in
vitro into GABAergic and Glutamatergic neurons, similar to their
wild-type counterpart [34]. Therefore, we analyzed the expression
of such neurotransmitters among the IhNSC-Ps’ progeny that
successfully engrafted in our model. We found both cells exhibiting
the GABAergic (Fig. 3G and inset) and glutamatergic (Fig. 3H and
inset) phenotypes in the corpus callosum and cortex, as early as 1
month after transplantation, which were still detectable 4 months
from transplantation. These findings show, for the first time, that
IhNSCs progeny can engraft in the adult brain as mature neuronal
cells expressing the GABAergic or the glutamatergic phenotypes.
Long-term survival of IhNSC-Ps
At the later time tested, i.e. 4 months (Fig. 4A, n=3) the presence
of IhNSC-P-derived cells was obvious in the corpus callosum,
wherein they migrated tangentially (4.360.6 mm medially and
4.560.45 mm laterally, n=3, Fig. 4B and C), also spreading into
the controlateral hemisphere (Fig. 4B). GFP+ cells were also
detected along the injection tract in the hippocampal fissure, along
the SGZ of the dentate gyrus (n=4) (average distance of migration
400 mm medially and 380 mm laterally to the injection site up to the
Figure 3. Differentiation of transplanted IhNSC-Ps in vivo. (A–F) IhNSC-Ps at 3 months post transplantation differentiate into both
NCAM+HuN+ (A, cc) and Dcx+/GFP+ (B, dentate gyrus) neuronal progenitors and b-Tub+HuN+ (C) and MAP2+HuN+ (D) mature neurons in the cortex.
(E) Sporadic proliferating cells (Ki67+HuN+, arrow and inset magnification). (F) GFAP+HuN+ astroglial cells in the cortex. (G–H) IhNSC-Ps at 1 month
from transplantation generate GABAergic (GABA+HuN+, arrow in G and inset magnification) and Glutamatergic neurons (GLUTA+HuN+, arrow in H
and magnification). Scale bars: A, B, C, E, F: 20 mm, D, inset in E, G, H, inset in H: 10 mm, inset in G: 5 mm.
doi:10.1371/journal.pone.0014035.g003
hNSCs into Ischemic Brain
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the ventricles (Fig. 4D–H). These results support the concept that,
immunologically, transplanted human cells are well tolerated by the
adult brain and that even a quite mild immunosuppression, like the
transient one used here, may be sufficient to accomplish their
efficient integration in the lesioned CNS tissue.
Migration of IhNSC-Ps’ progeny and long-term
integration into the CA1 layer
The CA1 layer of the hippocampus is one of the areas most
prominently damaged in transient global ischemia. In addition,
neurons newly generated by adult neurogenesis in the CA1
pyramidal layer also die, due to the persistence of inflammatory
conditions [35]. Consistently with these findings, we were unable
to detect IhNSC-Ps in the CA1 pyramidal layer at 1, 2 or 3
months after transplantation. At 4 months after ischemia, we
found that some IhNSC-Ps did integrate along the CA3 layer
(n=2), sending processes toward the CA1 layer (Fig. 5A–D) and
migrating to the underlying SVZ (Fig. 5C). Unexpectedly, IhNSC-
Ps were also found as irregular clusters, distributed along the CA1
layer (n=4), with their nuclei organized according to the classic
multilayer pattern of the CA1 layer (Fig. 5E). These observations
show that, despite the persistence of inflammation in this region
[35], IhNSC-Ps retain the ability to interact with the to host
endogenous neurogenic pathways, suggesting that they can
undertake appropriate differentiation and contribute to the local
regeneration of the damaged hippocampal tissue.
IhNSC-P derived neurons establish synaptic junctions in
vivo
Since neither electrophysiological recordings on adult rat
brain slices nor high resolution immunofluorescence analysis
Figure 4. Long-term survival of IhNSC-Ps after transient immunosuppression. (A) Map of the brain areas colonized by IhNSC-Ps in
transiently immunosuppressed ischemic rats 4 months following transplantation. Letters in boxed area refer to the figures B–E. IhNSC-Ps migrate
extensively through the cc (B–C) and along the dentate gyrus (D, E and H) to the underling SVZ (D, E). F and G magnifications of boxed areas in E.
Scale bars: B,C,E,F,G and H: 50 mm; D: 100 mm.
doi:10.1371/journal.pone.0014035.g004
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tissue cytoarchitecture, we assessed the ultrastuctural features of
GFP-expressing IhNSC-Ps progeny located in the CA1 layer, 4
months after transplantation (Fig. 5E). In the hippocampus, GFP
immunoreactivity was present within IhNSC-P-derived cell
processes, mainly distributed along the cytoskeleton. Despite
the disorganization of the ischemic tissue, we observed reci-
pient axons (GFP-negative, a in Fig. 6A-C), possibly pyramidal
neurons in the CA1 layer of the hippocampus, making synaptic
contacts with the GFP-labeled processes (d in Fig. 6A-C). GFP-
labeled myelinated axons were also detected (Fig. 6D and E).
This was similar to the GFP-labeling pattern observed in cultured
IhNSC-Ps, which was associated with microtubular structures
(Fig. 6G) and could not be oserved in the non-transduced control
cells (Fig. 6F).
This supports the notion that surviving IhNSC-Ps progeny have
the ability to integrate into the lesioned CA1 area, therein
establishing heterotypic synaptic junctions with host cells.
IhNSC-Ps can modulate the inflammatory response in the
post-ischemic hippocampus
NSCs can act as immunomodulators in pathological, inflam-
matory brain environments [20,26,36–38]. We have analyzed
both the quantitative reduction and morphological changes in
reactive microglial Iba1+ cells and GFAP+ astrocytes, in post-
ischemic hippocampal area after IhNSC-Ps transplantation.
As shown in Fig. 7A, B, 1 week after transplantation, the
inflammatory reaction was significantly reduced in the transplant-
ed hemisphere as compared to the controlateral one (Fig. 7C, D),
which displayed an inflammation pattern comparable to that
Figure 5. At four months after transplant IhNSC-Ps integrate in the hippocampal layers under transient immunosuppression. (A)
Schematic map of the hyppocampal layers colonized by IhNSC-Ps in transiently immunosuppressed ischemic rats. The letters are positioned next to
the regions referred to the figures B–E. (B–D) At 4 months following transplantation IhNSC-Ps were found integrated into the CA3 layer and in the
underling SVZ (B), emitting long processes toward the dentate gyrus (boxed area in B, shown at higher magnification in (C) and CA1 layer (B–D). (E) At
this time IhNSC-Ps were also found distributed along the CA1 layer. Scale bars: in B–D: 50 mm, in E: 30 mm.
doi:10.1371/journal.pone.0014035.g005
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fraction of Iba1+ cells in the ipsilateral emisphere amounted to
9.4563.06% of total cells in the area as compared to
14,7163.23% in the controlateral one (n=3). Similarly GFAP+
cells in the ipsilateral side were 8.6361.07% of the total cells,
much less than the 13.1362.69% detected controlaterally. This
difference was even more striking at a later time, i.e. at 14 DAI
(Fig. 7E and F), when the inflammatory reaction induced by the
lesion is known to reach its peak: the fractions of Iba1+ cells were
10.5762.64% and 29.3667.8% and those of GFAP+ cells
6.962% and 31.6563.11% in the transplanted and control
hemispheres, respectively (n=3 each). Moreover, the morphology
of both Iba1+ and GFAP+ cells appeared to shift from ameboid
and globular, typical of a reactive phenotype, to branching and
star-shaped, like in resident cells. At 1 month after lesion
inflammation had subsided in both sides and, no significant
differences were detectable between the two hemispheres (Fig. 7A
and B, G and H).
It is worth noting that immunosuppression by cyclosporine, be it
administered transiently or even continuously, did not affect
inflammatory response in lesioned animals, as assessed by
immunofluorescence using anti-Iba1 antibody (not shown).
Discussion
Cell survival and migration
In the adult brain, ischemia and brain trauma increase
neurogenesis in the SVZ and migration of newly generated
NSC-derived progenitors to the sites of injury [39,40]; however
this self-repair process is limited [7], so that cell therapy through
transplantation of exogenous neural cells has been envisioned as a
candidate therapeutic approach [13,41–43]. The present study
Figure 6. IhNSC-Ps form synapses into the rat hippocampus. Representative electron micrographs of rat hippocampus (A–E) and IhNSC-Ps
differentiated in vitro (F–G), immunostained for GFP. (A–C) GFP immunopositive dendrites (d) on which unstained axons (a) project, making synaptic
contacts (arrows). (D, E) GFP immunopositive myelinated axons (a). (F) Sham transfected IhNSC-Ps in culture. (G) GFP expressing IhNSC-Ps in culture.
To note, GFP is mainly associated to microtubular structures. Scale bars: 500 nm.
doi:10.1371/journal.pone.0014035.g006
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migration and differentiation in the adult brain following and
ischemic lesion, in view of their perspective use in modeling neural
transplantation of human neural cells in ischemia and as a source
of cells for cell replacement therapy.
IhNSCs can generate significant percentages of mature neurons
and oligodendrocytes in vitro [14]. Thus, we investigated their ability
to do the same in vivo, in the brain of adult rats which suffered
transient global ischemia, causing a widely distributed brain injury
that primarily affects the neocortical and the hippocampal CA1
Figure 7. Effect of IhNSC-Ps on microglia and astrocyte activation. (A–B) Charts showing the effect of IhNSC-Ps transplantation on the
number of microglia (Iba1+, A) and astroglial cells (GFAP+, B) in the hippocampal region at 7, 14 and 30 DAI. (C–H) Representative images of the
hippocampal regions, showing the morphology and density of Iba1+ cells (green) and GFAP+ cells (red) in not transplanted (C, E, and G) and
transplanted (D, F and H) brain hemispheres at 7, 14 and 30 DAI. Abbreviations: cc = corpus callosum. Scale bars: 50 mm.
doi:10.1371/journal.pone.0014035.g007
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impaired when grafted within the severely lesioned area in ischemic
lesion, but not in the surrounding area [44], the latter was chosen as
elective site of injection of the cells. More specifically, IhNSC-Ps
were transplanted in the posterior periventricular region, below the
neocortical layers and in the hippocampal fissure below the
damaged CA1 region. The first evidence to emerge was that the
survival rate of the grafts was higher when cells were injected into
the posterior periventricular region next to the cc (81.2% of cc
transplanted animals, n=13/16) than in hf (53.3% of hf
transplanted animals, n=8/15). Also, quite remarkably, IhNSC-
Ps which were transplanted in the cc showed a preferential tropism
for the lesioned cortex, while IhNSC-Ps injected into the hf
migrated primarily to colonize the NSC niche in the DG (SGZ).
This seems to suggest the existence of differential, locoregional
instructive cues in these brain regions, although this phenomenon
shall require a specific investigation to be fully unraveled, also
considering the proximity of the two injection sites.
We found that, even upon the transient immunosuppression
conditions used here, IhNSC-Ps integrated into the cortex, corpus
callosum and DG of the hippocampus as early as 14 DAI, also
migrating along preferential neurogenic pathways [31], acquiring
a typical neuronal morphology. By 30 DAI, IhNSC-Ps injected in
the periventricular region were migrating tangentially along the cc,
as shown by previous studies [45]. Consistent with this pattern,
IhNSCP-derived cells were found in the controlateral hemisphere,
diffusely spreading through the white matter, 4 months post
implantation. When injected in the proximity of the DG, IhNSC-
Ps migrated along the SGZ (30 DAI), possibly attracted by
endogenous environmental cues secreted by the activated stem cell
niche layer [32]; in accordance with these observations, at the
endpoint of the analysis, we detected IhNSCP-derived cells being
distributed all along the medial dorsal wall of the SVZ in the 3
rd–
4
th ventricle. The evidence above seems to suggest the existence of
differential, locoregional instructive cues in the cc and DG,
although this phenomenon shall require a full blown study to be
fully unraveled.
At least 19% of the grafted human cells survived 1 month after
transplantation, a percentage similar to that observed after 4
months. This would suggest a quite stable profile of integration
and survival of the transplanted cells over a quite long period.
Nonetheless, it is also possible that this apparent stability in the
overall number of grafted cells may be the consequence of a
dynamic balance between two competing processes, the death of
engrafted cells and the birth of new ones through cell proliferation.
In fact, it is well known that stroke-associated hypoxia enhances
the proliferation of neuronal precursors [40,46,47] and, in
agreement with this, we documented the sporadic presence of
Ki67+ elements among our donor cells.
Only 7 out of 28 of the transplanted control (unlesioned)
animals showed appreciable cell engraftment and survival with
respect to 37 out of 61 in lesioned animals. Furthermore, in
control animals, engrafted cells were mainly localized next to the
injection site (not shown). These results are in good agreement
with previous studies, showing that both IhNSC-Ps survival and
migration are enhanced by the presence of a brain lesion as
compared to the healthy CNS tissue [29]. Finally, the transplanted
IhNSC-Ps were not tumorigenic, in accordance with our earlier
findings in SCID mice [14]. Our findings are also consistent with
studies carried out with primary cultures of human progenitors
[40,48,49] and provide the initial evidence that neural progenitors
that are continuously produced by a renewable source of hNSCs
can undergo targeted migration to different areas in the adult
brain affected by a global ischemic lesion.
IhNSC-Ps proliferation and differentiation
Others and us have previously shown that NSCs undergo
prevalent glia differentiation after transplantation in neurodegen-
erative disease animal models such as metachromatic leukodys-
trophy (MLD) [20], focal demyelination [24] and multiple sclerosis
(MS) [38]. In order to enhance the neuronogenic potential of
IhNSCs, in this study we transplanted neural progenitors derived
from IhNSCs (IhNSC-Ps) which were pre-committed to differen-
tiation in vitro and cultured at 5% oxygen, a condition
approximating the physiological range of oxygen in the SVZ
and DG [50]. As early as 1 month from transplantation into the
brain of ischemic adult rats, clusters of HuN+ cells expressed
markers of early neuronal progenitors (Dcx+ and NCAM+), and
we also identified HuN+/b-Tub+ and HuN+/MAP2+ neurons
with ramificated morphology and typically star-shaped HuN+/
GFAP+ astrocytes. The expression of these markers was
maintained at 4 months from transplantation when IhNSC-Ps
appeared widely distributed in the corpus callosum and cortex,
where we could detect HuN+ cells bearing GABAergic or
Glutamatergic phenotypes, consistent with their physiological
prevalence in these brain areas and with the pattern of in vitro
differentiated hNSCs and IhNSCs [14,34]. To note, the synthesis
of GABA by newborn neurons and active cortical neurogenesis by
resident progenitors of layer 1 have been recently shown to be a
fundamental requisite to restore neuronal function after stroke
[33,51]. Intriguingly, we also found sporadic MAP2+/hu-
manKi67+ cells at 3 months post ischemia, which completely
disappear at 4 months, indicating that at least a fraction of IhNSC-
Ps undergo transient short–term proliferation, also favoured by the
local specific environmental cues [33]. Most importantly, our
findings show the expression of both GABA and Glutamate
neurotransmitters by a renewable source of human cells
transplanted in a lesioned adult rodent brain.
IhNSC-Ps are not immunogenic under transient
immunosuppression treatment
A wide array of studies have shown that NSCs are not
susceptible to immunological rejection [15–18] even when
transplanted in animal models like EAE, characterized by a
constitutively activated immunological response [25,26]. Notably,
others and us have documented the ability of NSCs to somewhat
modulate or even dampen immunological response upon trans-
plantation [26,36,38,43]. This phenomenon may, in fact,
participate in the low immunogenic response that these cells seem
to elicit in the CNS. Notwithstanding, it is also true that some level
of immune surveillance is maintained in the adult brain upon
NSCs engraftment, which explains the widespread need to use
immune suppression [18] in experimental and clinical intracere-
bral transplantation [15,17].
The succesful use of transient immunosuppression described
here, supports the twofold notion of limiting toxicity in an
experimental model plagued by high animal mortality and of
preventing the bias introduced by the known neuroprotective
effects of cyclosporine following hypoxia-ischemia [52], and
proposes a suitable milder approach to immunosuppression for
the prospective use hNSCs for clinical purposes. That the
discontinuous treatment with cyclosporine does not affect
integration of transplanted cells in most of the brain regions,
which to all effects emerge as immunoprivileged when considering
hNSCs, is in good accordance with most recent findings [18]. It
should also be noted that the rate of survival of our transplanted
IhNSC-Ps appeared more prominent than that observed in
xenografts of embryonic human neural precursor cells [53],
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[15] or of adult human NPCs in ischemic rats [17].
Generation of mature neurons and reduction of the
inflammation by IhNSC-Ps in ischemia
Our ultrastructural analysis determined the full maturation of
IhNSCs progeny by detecting the presence of newly established
synaptic junctions between rat axonal terminals and IhNSC-Ps
progeny dendritic spines in the CA1 layer, 4 months after
transplantation. This is consistent with previous observations,
showing the ability of IhNSCs to generate post-synaptic structures
and to fire spontaneous action potentials in culture [14] and is
further supported by the detection of GFP labeled axons
enveloped by a multilayered myelin structure. Given the
prolonged timing required by human neural progenitors to
mature in vivo, analysis at further time points could provide
additional details on the functional integration of transplanted cells
in the damaged neuronal circuitry. Unfortunately, the age and size
of adult rats, combined with the dysplastic condition of the
ischemic brain tissue allowed neither electrophysiological studies,
nor an ultrastructural investigation beyond the 4 month end/
point.
Besides neurodegeneration per se, one of the hallmarks
characterizing most neurodegenerative disorders like stroke, AD,
PD, ALS, MLD [37], is the development of an inflammatory
environment, which can contribute to tissue damage. Recent
studies have shown that NSCs may also exert their therapeutic
potential through an immunomodulatory action [26,36,38]. Our
study reports that transplantation of IhNSCs can effectively
decrease reactive astrogliosis and dumpen microglial activation in
the injuried areas. This effect occurred exclusively in the
transplanted regions and was most prominent at 15 days from
transplantation, when the inflammatory reaction appeared to
reach its nadir. There was an obvious effect on the state of
activation of microglia, whose cells shifted from the activated,
macrophagic-amoeboid phenotype to the resting, stellate one, with
a concomitant shift of astrocytes from fibrotic and globular to star-
shaped and long-branching in the transplanted areas.
Conclusion
Transient global ischemia is a commonly accepted model of
vascular dementia, since it resembles the pathological features of
Alzheimer’s Disease. In this view, the findings presented in this
manuscript lend to the idea of using IhNSCs as a suitable tool to
model transplantation of hNSCs in pre-clinical settings. This is
particularly relevant in view of the fact that the first phase I clinical
trial exploiting cell therapy has been authorized and is currently
underway. The trial uses non-immortalized neural cells similar to
those described here, which may thus be considered for a
prospective use in clinical settings. This is particularly true,
considering the suitable migration and differentiation pattern of
our IhNSCs in the ischemic brain, their negligible rejection, their
ability to establish synaptic interaction with host cells and their
capacity to generate appropriate neurotransmitter phenotypes in
ischemia target areas, such as the hippocampus and cortex. The
ability of transplanted IhNSC-Ps to dampen reactive astrogliosis
and microglia activation provide an extra positive element when
considering hNSCs for therapeutic purposes in neurodegenerative
disorders.
Supporting Information
Figure S1 Analysis of the lesioned brain at 3DAI. (A–C)
Hematoxylin-eosin showing the pyknotic nuclei present in the
lesioned (A, arrows) respect to the control cortex (B), and in the
lesioned CA1 layer (C). (D–E) Microglial (Iba1+, D) and astroglial
(GFAP+, E) reaction in the hippocampal region of lesioned
animals at 3DAI. (F) Quantification of pyknotic nuclei in the CA1
layer and of Iba1+ and GFAP+ cells in the hippocampal region.
Scale bar: A and B: 50 mm, C: 5 mm, D and E: 75 mm.
Found at: doi:10.1371/journal.pone.0014035.s001 (5.38 MB TIF)
Figure S2 In vitro differentiation of IhNSC. (A–E) IhNSC-P used
for transplantation contained early neuronal progenitors (Dcx+,A
and NCAM+, B), neurons (b-Tub+, C and MAP2+, D), astrocytes
(GFAP+, C), oligodendrocytes (GalC+, E) and a percentage of
residual proliferating cells (Ki67+, A, B and D). (F) Quantification
of the neural cell lineages in IhNSC-P. Scale bars: A–E: 10 mm.
Found at: doi:10.1371/journal.pone.0014035.s002 (5.00 MB TIF)
Figure S3 Experimental design. (A) Schematic representation
showing the experimental plan with transplanted animals
undergoing transient or constitutive immunosuppression. Healthy
not transplanted animals (n=4) have been excluded. (B) Table
showing the numerosity of the transplanted animal groups.
Abbreviations: cc: corpus callosum, hf: hippocampal fissure, AP:
anteroposterior, L: lateral, DV: dorsoventral.
Found at: doi:10.1371/journal.pone.0014035.s003 (9.30 MB TIF)
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